Boardroom Alpha
Boardroom Alpha
AVY · Current Report (Form 8-K) · Filed August 19, 2026

Avery Dennison Corp — Current Report (Form 8-K)

Form
8-K
Filed
August 19, 2026
Period
Aug 18, 2026
Ticker
AVY
Accession
0000008818-26-000141
Boardroom Alpha · Filing insights

William Wagner named independent Board Chair effective Sept 1, 2026. Patrick Siewert to become Chair for the term.

About Avery Dennison Corp
Market cap
$13.5B
1Y TSR
+5.6%
3Y TSR
+1.0%
Board grade
C
Sector
Consumer Cyclical
CEO
Deon Stander
Last annual meeting: Apr 30, 2026 · View full Avery Dennison Corp profile →
avy-20260818

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
August 18, 2026
Date of Report (Date of earliest event reported)
AVERY DENNISON CORPORATION
(Exact name of registrant as specified in its charter)
 
Delaware
 
1-7685
 
95-1492269
 
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
 
8080 Norton Parkway            
Mentor, Ohio
44060
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code (440) 534-6000
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, $1 par valueAVYNew York Stock Exchange
3.750% Senior Notes due 2034AVY34Nasdaq Stock Market
4.000% Senior Notes due 2035AVY35Nasdaq Stock Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Section 8 — Other Events

Item 8.01 Other Events.
On August 18, 2026, consistent with its thoughtful long-term Board leadership succession planning process, the Board of Directors (the “Board”) of Avery Dennison Corporation, a Delaware corporation (the “Company”), unanimously elected William Wagner as independent Board Chair, effective September 1, 2026, to serve in such capacity for the remainder of the one-year term ending at the 2027 Annual Meeting of Stockholders (the “Annual Meeting”). Mitchell Butier will continue to serve as non-executive Chairman through August 31, 2026 and as a non-independent member of the Board for the remainder of the one-year term ending at the Annual Meeting. Mr. Wagner has served as an independent member of the Board since October 2022, and currently serves as Chair of the Governance Committee and the Cybersecurity Committee.
The Board previously determined that Mr. Wagner is independent under New York Stock Exchange listing standards such that a Lead Independent Director is no longer required under the Company’s Corporate Governance Guidelines. As a result, Patrick Siewert will cease serving as Lead Independent Director on August 31, 2026 and continue to serve as an independent member of the Board for the remainder of the one-year term ending at the Annual Meeting.
Also on August 18, 2026, in light of the time commitments associated with Mr. Wagner’s role as independent Board Chair and his continuing service as Chair of the Cybersecurity Committee, the Board appointed Mr. Siewert, who currently serves as a member of the Governance Committee, to replace Mr. Wagner as its Chair, effective September 1, 2026, to serve in such capacity for the remainder of the one-year term ending at the Annual Meeting. Mr. Wagner will continue to serve in such capacity through August 31, 2026 and as a member of the Committee for the remainder of the one-year term ending at the Annual Meeting.



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
AVERY DENNISON CORPORATION
Date: August 19, 2026By:/s/ Deon M. Stander
Name:
Title:  
Deon M. Stander
President and Chief Executive Officer

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Avery Dennison Corp (AVY)

Reference

Frequently asked questions

When did Avery Dennison Corp file this 8-K?
Avery Dennison Corp (AVY) filed this Current Report (Form 8-K) with the SEC on August 19, 2026. The accession number assigned by EDGAR is 0000008818-26-000141.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
William Wagner named independent Board Chair effective Sept 1, 2026. Patrick Siewert to become Chair for the term. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Avery Dennison Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Avery Dennison Corp has filed under CIK 8818, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer